Navigation Links
PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer
Date:2/24/2009

MOUNTAIN VIEW, Calif., Feb. 24 /PRNewswire/ -- PolyRemedy, Inc., a manufacturer of point-of-care robotic systems for the fabrication and tracking of customized, nano-material-based wound treatments, has hired Jeffrey S. Jones to serve as the Company's chief operating officer (COO). Jones, a seasoned healthcare executive, joined the PolyRemedy management team in January 2009.

"With his experience in growing innovative medical device companies, Jeff brings a proven track record of driving change and achieving results in high growth environments," says Dan Eckert, president and chief executive officer of PolyRemedy. "With a national priority on reducing healthcare costs while improving the quality of care, the timing is great for us to introduce an evidence-driven wound care treatment system, and we are thrilled to have Jeff's experience and leadership on our team as we continue to build our company."

"PolyRemedy's expertise in providing customized wound treatments with objective wound care information is truly unique. We have a real opportunity to improve wound care outcomes," Jones says. "I look forward to working with everyone at PolyRemedy to deliver our innovative wound care treatment approach to the market." As COO, Jones is responsible for managing all aspects of PolyRemedy operations, including manufacturing, research and development, product engineering, software development, information technology, quality assurance, regulatory, materials, purchasing, customer and field service.

Prior to joining PolyRemedy, Jones served as COO at Reliant Technologies, a medical device company in Mountain View, Calif., that developed and launched the innovative Fraxel Laser for skin resurfacing. While there, Jones built strong operations, product engineering, regulatory, quality assurance and an in-house medical clinic to support product launches. By the time Reliant was acquired by Solta Medical in 2008, Jones had helped to grow the company revenue to an $88 million annual run rate.

Previously, Jones was COO at LuMend, Inc., Redwood City, Calif., an interventional cardiology medical device company and vice president of operations at EP Technologies, a subsidiary of Boston Scientific Corporation, San Jose, Calif., an interventional cardiology medical device company. Earlier in his career, Jones held various management positions, including director of Fiber Products Group at Coherent Inc., Palo Alto, Calif., a medical laser system company, and manager of Test and Test Engineering at Hughes Aircraft Company, Fullerton, Calif. Jones was also a captain in the U.S. Army.

Jones received a bachelor's degree in engineering from the United States Military Academy, West Point, NY, and an MBA from Golden Gate University, San Francisco.

About PolyRemedy

PolyRemedy, based in Mountain View, Calif., manufactures robotic systems for the fabrication of nano-fiber wound treatments, on demand and at the point of care. The innovative PolyRemedy system produces customized wound dressings within minutes, measured to fit the wound size and shape and fabricated with the precise material composition necessary to optimally treat the wound. The system also captures and monitors important wound treatment data with the potential to help evaluate costs, refine clinical protocols, and demonstrate evidence-based improvements in wound management.


'/>"/>
SOURCE PolyRemedy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PolyRemedy Hires Gary Coughlen as CFO
2. PolyRemedy Strengthens Executive Team With Additions of Diane Cooper, PhD, and Joe Coyne
3. Digirad Names Richard B. Slansky Chief Financial Officer
4. Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman
5. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
6. maxIT Healthcare Names David H. Tucker as National Accounts Business Director
7. Innerscope Research(TM) Names Caleb Siefert as Senior Scientist to Lead Companys Statistical Analyses and Study Designs
8. S.C.-Based Technology Consortium Names Interim Executive Director and Board
9. NHP Names New Chairman and Lead Independent Director
10. The SCAN Foundation Names New Members to Its Board
11. JNCCN Names New Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: